{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:17:21Z","timestamp":1762917441679},"reference-count":86,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":930,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1111\/ane.12067","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T14:52:58Z","timestamp":1360767178000},"page":"362-370","source":"Crossref","is-referenced-by-count":33,"title":["Differentiation of Progressive Supranuclear Palsy: clinical, imaging and laboratory tools"],"prefix":"10.1155","volume":"127","author":[{"given":"R. M.","family":"Liscic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Srulijes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Maetzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2013,2,13]]},"reference":[{"key":"10.1111\/ane.12067-BIB0001|ane12067-cit-0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"Suppl 5","key":"10.1111\/ane.12067-BIB0002|ane12067-cit-0002","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/ana.10570","article-title":"Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia","volume":"54","author":"Boeve","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12067-BIB0003|ane12067-cit-0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive Supranuclear Palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12067-BIB0004|ane12067-cit-0004","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awf109","article-title":"Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy","volume":"125","author":"Morris","year":"2002","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0005|ane12067-cit-0005","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awh488","article-title":"Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism","volume":"128","author":"Williams","year":"2005","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0006|ane12067-cit-0006","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mds.22977","article-title":"What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?","volume":"25","author":"Williams","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0007|ane12067-cit-0007","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/brain\/awm104","article-title":"Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome","volume":"130","author":"Williams","year":"2007","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0008|ane12067-cit-0008","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrneurol.2011.43","article-title":"Corticobasal degeneration: a pathologically distinct 4R tauopathy","volume":"7","author":"Kouri","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1111\/ane.12067-BIB0009|ane12067-cit-0009","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/mds.20478","article-title":"Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome","volume":"20","author":"Tsuboi","year":"2005","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0010|ane12067-cit-0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","article-title":"Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges","volume":"8","author":"Williams","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12067-BIB0011|ane12067-cit-0011","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0012|ane12067-cit-0012","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/mds.23336","article-title":"Clinical correlates of similar pathologies in parkinsonian syndromes. [Research Support, Non-U.S. Gov't]","volume":"26","author":"Song","year":"2011","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0013|ane12067-cit-0013","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jnnp.68.4.434","article-title":"What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?","volume":"68","author":"Wenning","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12067-BIB0014|ane12067-cit-0014","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/117.4.835","article-title":"Clinical features and natural history of multiple system atrophy. An analysis of 100 cases","volume":"117","author":"Wenning","year":"1994","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0015|ane12067-cit-0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/WCO.0b013e3283480569","article-title":"New insights into atypical parkinsonism","volume":"24","author":"Wenning","year":"2011","journal-title":"Curr Opin Neurol"},{"key":"10.1111\/ane.12067-BIB0016|ane12067-cit-0016","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00415-010-5645-x","article-title":"Urodynamic analysis in multiple system atrophy: characterisation of detrusor-sphincter dyssynergia","volume":"257","author":"Bloch","year":"2010","journal-title":"J Neurol"},{"key":"10.1111\/ane.12067-BIB0017|ane12067-cit-0017","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/mds.21083","article-title":"Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy","volume":"21","author":"Lee","year":"2006","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0018|ane12067-cit-0018","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-7091-6641-3_15","article-title":"Vascular progressive supranuclear palsy","volume":"42","author":"Winikates","year":"1994","journal-title":"J Neural Transm Suppl"},{"key":"10.1111\/ane.12067-BIB0019|ane12067-cit-0019","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20083","article-title":"Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis","volume":"19","author":"Zijlmans","year":"2004","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0020|ane12067-cit-0020","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0021|ane12067-cit-0021","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00702-010-0563-8","article-title":"In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism","volume":"118","author":"Srulijes","year":"2011","journal-title":"J Neural Transm"},{"key":"10.1111\/ane.12067-BIB0022|ane12067-cit-0022","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2004.11.008","article-title":"From trepidant abasia to motor network failure-gait disorders as a consequence of subcortical vascular encephalopathy (SVE): review of historical and contemporary concepts","volume":"229-230","author":"Baezner","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1111\/ane.12067-BIB0023|ane12067-cit-0023","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1111\/ane.12067-BIB0024|ane12067-cit-0024","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s004010000283","article-title":"Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy","volume":"101","author":"Arai","year":"2001","journal-title":"Acta Neuropathol"},{"issue":"Suppl 2","key":"10.1111\/ane.12067-BIB0025|ane12067-cit-0025","doi-asserted-by":"crossref","first-page":"II6","DOI":"10.1007\/BF03161076","article-title":"Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration","volume":"246","author":"Dickson","year":"1999","journal-title":"J Neurol"},{"key":"10.1111\/ane.12067-BIB0026|ane12067-cit-0026","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/brain\/119.4.1123","article-title":"The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases","volume":"119","author":"Verny","year":"1996a","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0027|ane12067-cit-0027","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s004010050446","article-title":"Progressive supranuclear palsy: a clinicopathological study of 21 cases","volume":"91","author":"Verny","year":"1996b","journal-title":"Acta Neuropathol"},{"key":"10.1111\/ane.12067-BIB0028|ane12067-cit-0028","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000121388","article-title":"Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy","volume":"5","author":"Jellinger","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1111\/ane.12067-BIB0029|ane12067-cit-0029","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1046\/j.1471-4159.1999.0721243.x","article-title":"Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively \u201cexon 10\u201d isoforms","volume":"72","author":"Sergeant","year":"1999","journal-title":"J Neurochem"},{"key":"10.1111\/ane.12067-BIB0030|ane12067-cit-0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00401-002-0531-y","article-title":"Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia","volume":"104","author":"Oide","year":"2002","journal-title":"Acta Neuropathol"},{"key":"10.1111\/ane.12067-BIB0031|ane12067-cit-0031","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5414\/NPP28046","article-title":"Hippocampal pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases","volume":"28","author":"Armstrong","year":"2009","journal-title":"Clin Neuropathol"},{"key":"10.1111\/ane.12067-BIB0032|ane12067-cit-0032","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1111\/ane.12067-BIB0033|ane12067-cit-0033","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1750-3639.1999.tb00552.x","article-title":"Alpha-synuclein in Lewy body disease and Alzheimer's disease","volume":"9","author":"Hashimoto","year":"1999","journal-title":"Brain Pathol"},{"key":"10.1111\/ane.12067-BIB0034|ane12067-cit-0034","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1111\/ane.12067-BIB0035|ane12067-cit-0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00401-011-0852-9","article-title":"Neuropathology underlying clinical variability in patients with synucleinopathies","volume":"122","author":"Halliday","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1111\/ane.12067-BIB0036|ane12067-cit-0036","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","article-title":"Hyperphosphorylated Tau in an alpha-synuclein-overexpressing transgenic model of Parkinson's disease","volume":"33","author":"Haggerty","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1111\/ane.12067-BIB0037|ane12067-cit-0037","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy","volume":"131","author":"O'Sullivan","year":"2008","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0038|ane12067-cit-0038","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneurol.2011.107","article-title":"Clinical correlates of white matter tract degeneration in progressive supranuclear palsy","volume":"68","author":"Whitwell","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12067-BIB0039|ane12067-cit-0039","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1212\/01.WNL.0000165960.04422.D0","article-title":"New and reliable MRI diagnosis for progressive supranuclear palsy","volume":"64","author":"Oba","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0040|ane12067-cit-0040","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mds.20877","article-title":"Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations","volume":"21","author":"Paviour","year":"2006b","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0041|ane12067-cit-0041","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/archneur.59.5.835","article-title":"Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm","volume":"59","author":"Bhattacharya","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12067-BIB0042|ane12067-cit-0042","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1212\/WNL.54.3.697","article-title":"Differentiation of atypical parkinsonian syndromes with routine MRI","volume":"54","author":"Schrag","year":"2000","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0043|ane12067-cit-0043","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1148\/radiol.2453061703","article-title":"MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy","volume":"246","author":"Quattrone","year":"2008","journal-title":"Radiology"},{"key":"10.1111\/ane.12067-BIB0044|ane12067-cit-0044","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/brain\/awl021","article-title":"Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy","volume":"129","author":"Paviour","year":"2006a","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0045|ane12067-cit-0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mds.23293","article-title":"MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease","volume":"26","author":"Longoni","year":"2011","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0046|ane12067-cit-0046","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mds.23529","article-title":"Accuracy of magnetic resonance parkinsonism index for differentiation of progressive supranuclear palsy from probable or possible Parkinson disease","volume":"26","author":"Morelli","year":"2011b","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"10.1111\/ane.12067-BIB0047|ane12067-cit-0047","doi-asserted-by":"crossref","first-page":"S711","DOI":"10.1002\/mds.22648","article-title":"Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. [Review]","volume":"24","author":"Hotter","year":"2009","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0048|ane12067-cit-0048","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/mds.23351","article-title":"Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy. [Comparative Study]","volume":"25","author":"Hussl","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0049|ane12067-cit-0049","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/WNL.0b013e31822e55d0","article-title":"MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study","volume":"77","author":"Morelli","year":"2011a","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0050|ane12067-cit-0050","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2967\/jnumed.108.059998","article-title":"Imaging approaches to Parkinson disease","volume":"51","author":"Brooks","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1111\/ane.12067-BIB0051|ane12067-cit-0051","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2463\/mrms.3.125","article-title":"Morning glory sign: a particular MR finding in progressive supranuclear palsy","volume":"3","author":"Adachi","year":"2004","journal-title":"Magn Reson Med Sci"},{"key":"10.1111\/ane.12067-BIB0052|ane12067-cit-0052","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1052-5149(03)00096-0","article-title":"The role of positron emission tomography imaging in movement disorders. [Review]","volume":"13","author":"Bohnen","year":"2003","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1111\/ane.12067-BIB0053|ane12067-cit-0053","first-page":"147","article-title":"Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders. [Review]","volume":"9","author":"Gerasimou","year":"2006","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1111\/ane.12067-BIB0054|ane12067-cit-0054","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/MNM.0b013e32833e5f90","article-title":"Preliminary studies of differential impairments of the dopaminergic system in subtypes of progressive supranuclear palsy","volume":"31","author":"Lin","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1111\/ane.12067-BIB0055|ane12067-cit-0055","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/mds.22662","article-title":"Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET","volume":"24","author":"Liepelt","year":"2009","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0056|ane12067-cit-0056","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.23975","article-title":"Fluorodeoxyglucose Positron Emission Tomography in Richardson's Syndrome and Progressive Supranuclear Palsy-Parkinsonism","volume":"27","author":"Srulijes","year":"2012","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0057|ane12067-cit-0057","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1212\/WNL.60.1.74","article-title":"Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes","volume":"60","author":"Walter","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0058|ane12067-cit-0058","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/mds.22981","article-title":"Substantia nigra echogenicity in progressive supranuclear palsy","volume":"25","author":"Ebentheuer","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0059|ane12067-cit-0059","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/jnnp.2004.049221","article-title":"Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound","volume":"76","author":"Behnke","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12067-BIB0060|ane12067-cit-0060","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1001\/archneur.64.11.1635","article-title":"Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease","volume":"64","author":"Walter","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12067-BIB0061|ane12067-cit-0061","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1586\/14737159.8.4.479","article-title":"Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases","volume":"8","author":"Tumani","year":"2008","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1111\/ane.12067-BIB0062|ane12067-cit-0062","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer's disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/ane.12067-BIB0063|ane12067-cit-0063","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/brain\/awq008","article-title":"DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease","volume":"133","author":"Hong","year":"2010","journal-title":"Brain"},{"key":"10.1111\/ane.12067-BIB0064|ane12067-cit-0064","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","article-title":"alpha-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study","volume":"10","author":"Mollenhauer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1111\/ane.12067-BIB0065|ane12067-cit-0065","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of alpha-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0066|ane12067-cit-0066","doi-asserted-by":"crossref","first-page":"430.e1","DOI":"10.1016\/j.neurobiolaging.2010.12.001","article-title":"CSF alpha-synuclein does not differentiate between parkinsonian disorders","volume":"33","author":"Aerts","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1111\/ane.12067-BIB0067|ane12067-cit-0067","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.parkreldis.2008.05.001","article-title":"Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders","volume":"15","author":"Constantinescu","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12067-BIB0068|ane12067-cit-0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and\/or Parkinsonian Disorders","volume":"27","author":"Hall","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1111\/ane.12067-BIB0069|ane12067-cit-0069","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.parkreldis.2009.07.007","article-title":"Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders","volume":"16","author":"Constantinescu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1111\/ane.12067-BIB0070|ane12067-cit-0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","article-title":"Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease","volume":"480","author":"Shi","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1111\/ane.12067-BIB0071|ane12067-cit-0071","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000329763","article-title":"Decreased alpha-Synuclein Serum Levels in Patients with Lewy Body Dementia Compared to Alzheimer's Disease Patients and Control Subjects","volume":"31","author":"Laske","year":"2011","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1111\/ane.12067-BIB0072|ane12067-cit-0072","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2007.08.010","article-title":"Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease","volume":"425","author":"Waragai","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1111\/ane.12067-BIB0073|ane12067-cit-0073","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.nbd.2011.08.003","article-title":"Post mortem cerebrospinal fluid alpha-synuclein levels are raised in multiple system atrophy and distinguish this from the other alpha-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies","volume":"45","author":"Foulds","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1111\/ane.12067-BIB0074|ane12067-cit-0074","doi-asserted-by":"crossref","first-page":"12670","DOI":"10.1016\/S0021-9258(19)86366-4","article-title":"Conservation of microtubule associated proteins. Isolation and characterization of tau and the high molecular weight microtubule associated protein from chicken brain and from mouse fibroblasts and comparison to the corresponding mammalian brain proteins","volume":"254","author":"Cleveland","year":"1979","journal-title":"J Biol Chem"},{"key":"10.1111\/ane.12067-BIB0075|ane12067-cit-0075","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neurobiolaging.2007.05.009","article-title":"Pattern of Tau forms in CSF is altered in progressive supranuclear palsy","volume":"30","author":"Borroni","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1111\/ane.12067-BIB0076|ane12067-cit-0076","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1212\/01.wnl.0000335941.68602.39","article-title":"Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy","volume":"71","author":"Borroni","year":"2008","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0077|ane12067-cit-0077","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1212\/WNL.0b013e318210e671","article-title":"Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. [Comment Letter]","volume":"76","author":"Kuiperij","year":"2011","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0078|ane12067-cit-0078","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/mds.22895","article-title":"Differential pattern of brain-specific CSF proteins tau and amyloid-beta in Parkinsonian syndromes","volume":"25","author":"Sussmuth","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12067-BIB0079|ane12067-cit-0079","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrneurol.2009.135","article-title":"Biological fluid biomarkers in neurodegenerative parkinsonism","volume":"5","author":"Eller","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.1111\/ane.12067-BIB0080|ane12067-cit-0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00415-010-5865-0","article-title":"Magnetic resonance imaging in progressive supranuclear palsy","volume":"258","author":"Stamelou","year":"2011","journal-title":"J Neurol"},{"key":"10.1111\/ane.12067-BIB0081|ane12067-cit-0081","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00702-002-0785-5","article-title":"Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD","volume":"110","author":"Yekhlef","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1111\/ane.12067-BIB0082|ane12067-cit-0082","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1212\/01.WNL.0000151854.85743.C7","article-title":"Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy","volume":"64","author":"Paviour","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0083|ane12067-cit-0083","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-0404.2006.00767.x","article-title":"Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging","volume":"116","author":"Cosottini","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/ane.12067-BIB0084|ane12067-cit-0084","first-page":"293","article-title":"Recent Developments in Parkinson's Disease, Vol 2. Florham","volume-title":"Members of the UPDRS Development Committee","volume":"153-63","author":"Fahn","year":"1987"},{"key":"10.1111\/ane.12067-BIB0085|ane12067-cit-0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1111\/ane.12067-BIB0086|ane12067-cit-0086","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12067","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12067\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:51:09Z","timestamp":1671540669000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,13]]},"references-count":86,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12067","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2,13]]}}}